Abstract

Klotho is an aging-suppressor gene. The purpose of this study is to investigate the binding sites (receptors) and function of short-form Klotho (Skl). We showed that Skl physically bound to multiple proteins. We found physical and functional interactions between Skl and S-formylglutathione hydrolase (FGH), a key enzyme in the generation of the major cellular anti-oxidant GSH, using co-immunoprecipitation-coupled mass spectrometry. We further confirmed the colocalization of Skl and FGH around the nucleus in kidney cells using immunofluorescent staining. Skl positively regulated FGH gene expression via Kid3 transcription factor. Overexpression of Skl increased FGH mRNA and protein expression while silencing of Skl attenuated FGH mRNA and protein expression. Klotho gene mutation suppressed FGH expression in red blood cells and kidneys resulting in anemia and kidney damage in mice. Overexpression of Skl increased total GSH production and the GSH/GSSG ratio, an index of anti-oxidant capacity, leading to a decrease in intracellular H2O2 and superoxide levels. The antioxidant activity of Skl was eliminated by silencing of FGH, indicating that Skl increased GSH via FGH. Interestingly, Skl directly interacted with FGH and regulated its function. Site-directed mutagenesis of the N-glycan-modified residues in Skl abolished its antioxidant activity, suggesting that these N-glycan moieties are important features that interact with FGH. Specific mutation of Asp to Ala at site 285 resulted in a loss of anti-oxidant activity of Skl, suggesting that N-glycosylation at site 285 is the key mechanism that determines Skl activity. Therefore, this study demonstrates, for the first time, that Skl regulates anti-oxidant GSH generation via interaction with FGH through N-glycosylation.

Highlights

  • formylglutathione hydrolase (FGH) may occur at the transcriptional (mRNA) and protein expression while silencing of short-form Klotho (Skl) attenuated FGH mRNA and protein expression

  • The recombinant Skl expressed in HEK293 cells was probed using Flag antibody to confirm the exogenous expression of Skl

  • We found that overexpression of Skl increased Kid3 expression while knockout of Skl using the Crispr/Cas9 system suppressed expression in HEK293 cells following overexpression of Skl. (*p < 0.05 vs. control, N = 3)

Read more

Summary

Introduction

FGH mRNA and protein expression while silencing of Skl attenuated FGH mRNA and protein expression. Klotho gene mutation suppressed FGH expression in red blood cells and kidneys resulting in anemia and kidney damage in mice. This study demonstrates, for the first time, that Skl regulates anti-oxidant GSH generation via interaction with FGH through N-glycosylation. The association between FGF23 and its receptors activates the mitogen-activated protein kinase (MAPK) cascade, inhibits phosphate reabsorption in kidney proximal tubule cells, and suppresses expression of sodium-dependent phosphate co-transporter type 2c, which mediates phosphate reabsorption. Klotho deficiency increases oxidative stress, contributing to aging phenotypes [7,8,9,10]. Two forms of Klotho have been identified: full-length Klotho (Fkl) and short-form Klotho (Skl) These two forms are generated by alternative RNA splicing of the KL gene. The purpose of this study is to identify the binding proteins of Skl and investigate their functional interactions.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call